The Business of Biotech: Engineering the Genome for Fun and Profit

by | Aug 15, 2015 | Newsletter | 1 comment

You’ve heard the scientific debate about GMOs, but what about the business of biotech? Where did this multi-billion dollar business come from? Who founded and funded the research centres that gave rise to these technologies, and what kind of return is to be gained on this investment? Who are the seed conglomerates that control so much of the food supply? Why are they building a doomsday seed vault in the Arctic as a “backup” for the world’s genetic heritage? Join James in this week’s subscriber newsletter as he peels back the veil on the biotech money trail.

For free access to this, and all of James’ subscriber editorials, please go to

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
To access this week’s edition of The Corbett Report Subscriber, please  and continue reading below.

Not a Corbett Report member yet? Sign up to BECOME A MEMBER of the website and read the full newsletter or ACCESS THE EDITORIAL FOR FREE on my Substack.


Become a Corbett Report member